Act One: An­ti-ag­ing team at Ju­ve­nes­cence adds $50M to the cache as it builds steam on de­vel­op­ment ef­forts

When Ju­ve­nes­cence got start­ed a year ago, the an­ti-ag­ing biotech had some big names at­tached but not big cash. To­day, they’re start­ing to se­ri­ous­ly make up for the gap.

The com­pa­ny, guid­ed by De­clan Doogan, Greg Bai­ley, An­nal­isa Jenk­ins, Jim Mel­lon and oth­ers, says it has round­ed up $50 mil­lion from an un­spec­i­fied set of “founders, in­sid­ers, in­sti­tu­tion­al in­vestors and fam­i­ly of­fices.” That brings the to­tal raise now to $63 mil­lion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER